Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2010
11/25/2010DE102009021681A1 New Staphylococcus aureus-binding peptide, comprising amino acid sections, useful for the enrichment, immobilization, detection and/or marking of Staphylococcus aureus
11/25/2010CA2762652A1 Novel solid materials of {[(2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
11/25/2010CA2762551A1 Cell-penetrating peptides
11/25/2010CA2762525A1 Marked peptides and use thereof for assaying circulating irap
11/24/2010EP2252628A1 Bombesin analog peptide antagonist conjugates
11/24/2010EP2252627A1 Lytic domain fusion constructs and methods of making and using same
11/24/2010EP2252576A2 Selective poly-n-substituted glycine antibiotics
11/24/2010EP1502949B1 Antimicrobial polypeptide and utilization thereof
11/24/2010EP0804572B1 Fusion protein comprising bpTK7
11/24/2010CN1927879B Thymopentapeptide active isomer and application thereof in pharmaceutical preparation
11/24/2010CN101891803A New cartilaginous affinity polypeptide sequence, screening method and application thereof
11/24/2010CN101891802A Polypeptide or derivative product for treating or preventing cancer and application thereof
11/24/2010CN101891801A Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof
11/24/2010CN101891800A Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof
11/24/2010CN101215324B Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes
11/24/2010CN101113164B 12 peptide specifically combined with tumor metastasis related protein PRL-3 and uses thereof
11/23/2010US7838560 Urokinase inhibitors, production and use thereof
11/23/2010US7838497 Pro-angiogenic peptides
11/23/2010US7838496 solid phase synthesis; solution phase synthesis; hairpin motifs; chemokine receptor 4 antagonists
11/23/2010US7838491 controlling hydroxyapatite crystal growth; stabilized cylindrical micelles; bone disorders
11/23/2010US7838266 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically
11/23/2010US7838260 Using synaptosome-associated protein of 25,000 (SNAP25)/green fluorescent protein fusion comprising serotype c1 recognition sequences as diagnostic and evaluative tool in characterizing clostridial toxins
11/23/2010US7838218 Light emitting probes
11/23/2010CA2385049C Cyclised conotoxin peptides
11/23/2010CA2258125C T-cell epitope peptides
11/18/2010WO2010132869A2 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
11/18/2010WO2010132609A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/18/2010WO2010131491A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/18/2010WO2010131452A1 Ttk peptides and vaccines including the same
11/18/2010WO2010130030A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
11/18/2010WO2010130007A1 Antimicrobial compounds
11/18/2010WO2010106441A3 Peptidomimetics for modulating interleukin-1 receptor
11/18/2010WO2010101627A3 Methods and systems for treatment and/or diagnosis
11/18/2010US20100292440 Binding Molecules for Human Factor VIII and Factor VIII-Like Proteins
11/18/2010US20100292438 Proteinaceous compounds
11/18/2010US20100292437 Polypeptides useful for appetite suppression
11/18/2010US20100292435 Insulinotropic peptide synthesis using solid and solution phase combination techniques
11/18/2010US20100292173 Wound Healing Compounds And Methods
11/18/2010US20100292164 Dimerized peptide
11/18/2010US20100292163 Antitumoral Compounds
11/18/2010US20100292161 Polypeptides and methods of use
11/18/2010US20100292160 Hla-a* 3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/18/2010US20100292157 Combination Treatments for Alzheimer's Disease and Similar Diseases
11/18/2010US20100292148 Targeted polylysine dendrimer therapeutic agent
11/18/2010US20100292147 Identification of the hepcidin binding site on ferroportin
11/18/2010US20100292137 Antibiotics and Methods For Producing Them
11/18/2010US20100292136 Polymyxin derivatives and uses thereof
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/18/2010US20100291675 IgM-MEDIATED RECEPTOR CLUSTERING AND CELL MODULATION
11/18/2010US20100291130 Cloned genome of infectious hepatitis c virus strain hc-tn and uses thereof
11/18/2010US20100291127 Tumor associated antigen peptides and use of same as anti-tumor vaccines
11/18/2010US20100291120 Peptides regulating the surface expression of the t cell receptor
11/18/2010US20100291093 Antibody-mediated disruption of quorum sensing in bacteria
11/18/2010US20100291048 Modification of CXCR4 using engineered zinc finger proteins
11/18/2010US20100290987 Methods and compositions for detecting and modulating o-glycosylation
11/18/2010CA2761901A1 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
11/18/2010CA2761622A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
11/18/2010CA2761393A1 Ttk peptides and vaccines including the same
11/18/2010CA2760519A1 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/17/2010EP2251344A1 Formulation of boronic acid compounds
11/17/2010EP2251041A2 Intramolecularly-quenched near infrared fluorescent probes
11/17/2010EP2250189A1 Glycopeptides and methods of making and using them
11/17/2010EP2250188A2 Polypeptides for microbial detection
11/17/2010EP2250187A2 Novel peptide and cosmetic and/or pharmaceutical composition containing same
11/17/2010EP2249857A2 Malaria vaccine compositions and constituents which elicit cell mediated immunity
11/17/2010EP2249856A2 Peptides that target dorsal root ganglion neurons
11/17/2010CN101888852A 癌症疫苗组合物 Cancer vaccine composition
11/17/2010CN101885759A Polypeptide capable of specifically bonding porcine reproductive and respiratory syndrome viruses, screening method thereof and use thereof
11/17/2010CN101885758A Auto-antigen epitope and encoding gene and application thereof
11/17/2010CN101885757A Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies
11/17/2010CN101884780A Use of hepcidin as a regulator of iron homeostasis
11/16/2010US7834144 Prion-specific peptoid reagents
11/16/2010US7834143 Cell surface receptor for use as tool in identifying modulators of vascular pressure
11/16/2010US7834141 Antiproliferative agents; gonadotropin releasing factor; binding to tumor and cancer cells; Chicken II GnRH analog; resistant to degradation by post-proline peptidases
11/16/2010US7833984 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer
11/16/2010US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target
11/16/2010US7833974 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders
11/16/2010US7833973 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions
11/16/2010US7833967 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
11/16/2010US7833535 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction
11/16/2010CA2405704C Bombesin analogs for treatment of cancer
11/16/2010CA2400872C Cyclic hexapeptide derivatives
11/11/2010WO2010129890A2 Compounds and methods for inhibiting platelet aggregation
11/11/2010WO2010128223A1 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
11/11/2010WO2010128096A1 Method for the preparation of cyclopeptides
11/11/2010WO2010127704A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
11/11/2010WO2010127640A1 High penetration prodrug compositions of peptides and peptide-related compounds
11/11/2010WO2010127400A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
11/11/2010WO2010105636A8 Topical compositions comprising interleukin-1 alpha and peptides and cosmetic methods thereof
11/11/2010WO2010091651A3 Novel antimicrobial peptides
11/11/2010WO2010085100A3 Novel cellular transmembrane domain and intracellular transduction system containing the same
11/11/2010US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations
11/11/2010US20100286368 Novel polypeptide and process for producing the same
11/11/2010US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents
11/11/2010US20100286366 Polypeptide libraries with a predetermined scaffold
11/11/2010US20100286363 Cyclic heptapeptide and use of the same
11/11/2010US20100286071 Finger-1 Peptide Analogs of the TGF-Beta Superfamily
11/11/2010US20100286070 Affinity tag
11/11/2010US20100286069 Cationic peptide for delivering an agent into a cell
11/11/2010US20100286067 Glycoconjugation of polypeptides using oligosaccharyltransferases